Fluorinov Pharma - Ownership and Business Overview

Life ScienceCompany

Fluorinov Pharma Ownership

Who owns Fluorinov Pharma?

Fluorinov Pharma is owned by Trillium Therapeutics. It was acquired on January 27, 2016.

Fluorinov Pharma Business Overview

Where is Fluorinov Pharma headquartered?

Fluorinov Pharma is headquartered in Toronto, Ontario.

What sector is Fluorinov Pharma in?

Fluorinov Pharma is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 292 acquisitions of life science companies in 2016, including 31 acquisitions by private equity firms, and 261 by strategics.

Fluorinov Pharma Inc.

MaRS Centre, South Tower, 101 College St. Suite 300, L-349,
Toronto, Ontario M5G 1L7
Canada,
(647) 260-7829
www.fluorinovpharma.com

Fluorinov Pharma Inc. is a privately-held oncology company. Fluorinov has developed a proprietary medicinal chemistry platform using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties, potentially leading to increased safety and efficacy.


 Subscribe to unlock this and 201,649
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.